tradingkey.logo

Inogen Inc

INGN
查看詳細走勢圖
5.660USD
0.0000.00%
收盤 02/06, 16:00美東報價延遲15分鐘
153.66M總市值
虧損本益比TTM

Inogen Inc

5.660
0.0000.00%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

0.00%

5天

-4.07%

1月

-22.68%

6月

-3.58%

今年開始到現在

-15.77%

1年

-46.65%

查看詳細走勢圖

TradingKey Inogen Inc股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Inogen Inc當前公司基本面數據相對非常健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在醫療設備與耗材行業排名65/205位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為13.00。中期看,股價處於下降通道。近一個月,市場表現非常差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Inogen Inc評分

相關信息

行業排名
65 / 205
全市場排名
175 / 4521
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Inogen Inc亮點

亮點風險
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
估值合理
公司最新PE估值-5.65,處於3年歷史合理位
機構減倉
最新機構持股19.79M股,環比減少18.29%
保羅都鐸瓊斯持倉
明星投資者保羅都鐸瓊斯持倉,最新持倉137.65K股

分析師目標

基於 2 分析師
買入
評級
13.000
目標均價
+122.60%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Inogen Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Inogen Inc簡介

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
公司代碼INGN
公司Inogen Inc
CEOSmith (Kevin R. M)
網址https://www.inogen.com/
KeyAI